Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
12/19/18 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 15
12/18/18 8-K Current report filing
Related Documents
5
12/14/18 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
10
12/14/18 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 10
12/11/18 8-K Current report filing 102
12/10/18 424B4 Prospectus filed pursuant to Rule 424(b)(4) 42
12/07/18 EFFECT Notice of Effectiveness 1
12/06/18 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
57
12/04/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
12/04/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2